Market LIVE
Published markets; coverage varies by country
Product profile · United States

SUBLOCADE

 ·  Patent Litigation & Settlement History ↓

IngredientBUPRENORPHINE
Application typeNDA
Application209819
Product001
Dosage formSOLUTION, EXTENDED RELEASE
RouteSUBCUTANEOUS
Strength100MG/0.5ML (100MG/0.5ML)
Approval date2017-11-30
Marketing statusPrescription
Status event—
ApplicantINDIVIOR
Product source

Current GenericRadar decision

Year2020
SelectionDEEP_REVIEW
ReviewFINAL_CHECKING
Anchor typeREGULATORY_EXCLUSIVITY
Anchor date2020-11-30
Patent anchor—
Exclusivity anchor2020-11-30
Protection date—
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2020. Anchor type: REGULATORY_EXCLUSIVITY. Patent anchor: not recorded. Exclusivity anchor: 2020-11-30. Anchor date: 2020-11-30. Patent tail: yes. Exclusivity tail: yes. Review status: FINAL_CHECKING. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
101982182031-06-06U U-2489———
———
105921682031-06-06U U-2489———
———
92720442031-06-06U U-2178———
———
92720442031-06-06U U-2177———
———
92720442031-06-06U U-2209———
———
92720442031-06-06U U-2176———
———
94984322031-06-06DP/U U-2179———
———
97824022031-06-06DP/U U-2208———
———
97824022031-06-06DP/U U-2176———
———
97824022031-06-06DP/U U-2180———
———
97824022031-06-06DP/U U-2207———
———
98272412031-06-06DP/U U-2211———
———
98272412031-06-06DP/U U-2181———
———
98272412031-06-06DP/U U-2210———
———
98272412031-06-06DP/U U-2174———
———
98272412031-06-06DP/U U-2206———
———
105583942031-06-25DP ————
———
89752702031-09-05DP/U U-2175———
———
89752702031-09-05DP/U U-2206———
———
89213872032-01-06DP/U U-2173———
———
89213872032-01-06DP/U U-2174———
———
110005202035-11-06U U-3111———
———
118396112035-11-06U U-3111———
———
126229042035-11-06U U-4528———
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
M-314—2028-02-21————Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.